Related Experiment Video
Updated: Nov 3, 2025

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Anti-NMDAR encephalitis for psychiatrists: the essentials.
Matthew Beattie1, John Goodfellow1, Maria Oto1
1Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, UK.
Psychiatrists should consider anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in young females presenting with psychiatric symptoms. Early diagnosis and immunotherapy significantly improve patient outcomes for this autoimmune condition.
Area of Science:
- Neurology
- Psychiatry
- Immunology
Background:
- Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder often presenting with psychiatric manifestations.
- This condition predominantly affects female adolescents and young adults, necessitating increased clinical awareness.
Purpose of the Study:
- To highlight the importance of recognizing anti-NMDAR encephalitis in psychiatric settings.
- To emphasize the benefits of early diagnosis and immunotherapy for improved long-term outcomes.
Main Methods:
- Review of clinical presentation, diagnostic criteria, and management strategies for anti-NMDAR encephalitis.
- Discussion of diagnostic tools including cerebrospinal fluid (CSF) and serum antibody testing.
- Consideration of neuroimaging and electroencephalogram findings.
Main Results:
- Psychiatric symptoms are the predominant initial presentation.
- Cerebrospinal fluid (CSF) antibody detection is the gold standard for diagnosis; serum testing is a less reliable alternative.
- Routine investigations may yield normal or non-specific results.
Conclusions:
- Prompt diagnosis and initiation of immunotherapy are crucial for better patient prognosis in anti-NMDAR encephalitis.
- Collaboration between psychiatry and neurology is essential for optimal patient care.
- While immunotherapy is effective, recovery can be prolonged, and relapses are possible.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Electroconvulsive Therapy
Psychosis: Goals of Pharmacotherapy
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Drug Therapy
Antianxiety Medications
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...